Please assess the completion status of the following clinical trial:

Trial Title: Role of On-site CT-derived FFR in the Management of Suspect CAD Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* New-onset chest pain suspicious for CAD~* Coronary CTA result showed that the diameter stenosis is between 30 and 90% in at least one major coronary artery (coronary artery diameter ≥ 2.5 mm)~* Intermediate-to-high pretest probability of CAD based on CAD Consortium Score~* No prior evaluation for this episode of symptoms~* Agree to participate in this clinical study and sign written informed consent~Exclusion Criteria:~* Diagnosed or suspected acute coronary syndrome requiring hospitalization or emergent testing~* Hemodynamically or clinically unstable condition systolic blood pressure \< 90 mmHg or serious atrial or ventricular arrhythmias~* Known CAD with prior myocardial infarction, percutaneous coronary intervention (PCI), coronary artery bypass graft (CABG), or any angiographic evidence of ≥ 50% stenosis in any major coronary artery~* Patients with left main branch stenosis ≥ 50% or major coronary artery stenosis \> 90%~* Known severe congenital, valvular (moderate and above), or cardiomyopathy process (hypertrophic cardiomyopathy or reduced systolic left ventricular function ≤ 40%) which could explain cardiac symptoms~* Unable to provide written informed consent or participate in long-term follow-up.

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- CTA/CT-FFR care group (Type: EXPERIMENTAL): If the subjects are randomly allocated to CT-FFR arm, they will be examined by on-site DeepFFR for three major epicardial coronary arteries. If the result of CT-FFR calculation is less than or equal to 0.8 in one or more major coronary arteries, the patient will be referred to ICA directly; if the result of CT-FFR value is more than 0.8, optimal medical therapy will be recommended. The decision on the mode of revascularization is left to the treating cardiologists and depends on local practice standard.
- Routine clinically-indicated diagnostic care group (Type: NO_INTERVENTION): If the subjects are randomized to usual care arm, attending physicians will decide the next step of diagnosis and treatment, such as exercise ECG, stress cardiac echo, cardiac MR, and SPECT. According to the results of examination combined with risk factors assessment and clinical manifestations, physicians should provide recommendation whether the subjects would undergo ICA or not.

Based on this trial design, predict the completion outcome and termination type (if applicable).